Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic

Reza Homayounfar1, Mahmood Jeddi-Tehrani2, Makan Cheraghpour3

  • 1Department of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.

Insights

Diet-induced obesity increases p53 and PTEN proteins in peripheral tissues, impairing insulin action. Pharmacological inhibition of p53 (pifithrin-α) improved insulin sensitivity, suggesting p53 as a potential therapeutic target for type 2 diabetes.

Area of Science:

  • Metabolic research
  • Molecular biology
  • Endocrinology

Background:

  • Diet-induced obesity is linked to insulin resistance.
  • The role of p53 in peripheral tissues during obesity is not fully understood.

Purpose of the Study:

  • To investigate the role of p53 in adipose and peripheral tissues in diet-induced obesity.
  • To evaluate the therapeutic potential of targeting p53 to ameliorate insulin resistance.

Main Methods:

  • Wistar rats were fed low-fat or high-fat diets for 12 weeks.
  • Some rats received pifithrin-α (PFT), a p53 inhibitor.
  • Serum parameters (insulin, glucose) and protein levels (p53, PTEN, AKT) were analyzed.

Main Results:

  • Obese rats showed increased body weight, insulin resistance, and elevated p53 and PTEN levels in peripheral tissues.
  • AKT activation was decreased in obese rats, correlating with higher p53 and PTEN.
  • Pifithrin-α treatment reduced p53 levels, enhanced AKT phosphorylation, and improved insulin sensitivity.

Conclusions:

  • p53 activation in peripheral tissues is associated with decreased insulin action in diet-induced obesity.
  • Targeting p53 pharmacologically offers a potential therapeutic strategy for type 2 diabetes.
  • p53 may act as a protective mechanism against chronic insulin elevation in obese individuals.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K